ConductScience.org, home
Papers
API referenceFor AI assistants

Paper458481

Prolonged azathioprine treatment of non-remitting multiple sclerosis.

Rosen JA. J Neurol Neurosurg Psychiatry, 1979. Cited by 44 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prolonged azathioprine treatment of non-remitting multiple sclerosis. Papers, record 458481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/458481

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prolonged azathioprine treatment of non-remitting multiple sclerosis.
PubMed
Journal
J Neurol Neurosurg Psychiatry
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.94
iCite
Revised in PubMed
2019-05-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rosen JAJ A

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AzathioprineMajor topic
Multiple SclerosisMajor topic
Adult
Female
Follow-Up Studies
Humans
Male
Middle Aged
Time Factors

Source PubMed

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
314,313,512PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.Ann N Y Acad Sci1965https://conductscience.org/library/papers/14313512PubMed
414,313,511PROGNOSTIC CRITERIA IN MULTIPLE SCLEROSIS.Ann N Y Acad Sci1965https://conductscience.org/library/papers/14313511PubMed
514,219,199CLINICAL STUDIES OF MULTIPLE SCLEROSIS IN ISRAEL. 3. CLINICAL COURSE AND PROGNOSIS RELATED TO AGE AT ONSET.Neurology1964https://conductscience.org/library/papers/14219199PubMed
614,449,435Experimental allergic encephalomyelitis: the effect of 6-mercaptopurine.J Exp Med1962https://conductscience.org/library/papers/14449435PubMed
713,773,723The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease.Brain1961https://conductscience.org/library/papers/13773723PubMed
813,717,158Lethality, duration, and mortality of disseminated sclerosis in Denmark.Acta Psychiatr Scand1961https://conductscience.org/library/papers/13717158PubMed
121,151,432The onset and progression of the lesion in multiple sclerosis.J Neurol Sci1975https://conductscience.org/library/papers/1151432PubMed
135,787,160Cyclophosphamide: effect on experimental allergic encephalomyelitis in Lewis rats.Science1969https://conductscience.org/library/papers/5787160PubMed
145,770,114Enhanced suppression of experimental allergic encephalomyelitis by combination chemotherapy with duazomycin-A and 6-mercaptopurine.Proc Soc Exp Biol Med1969https://conductscience.org/library/papers/5770114PubMed
154,119,511Multiple sclerosis unaffected by azathioprine in pilot study.Arch Neurol1973https://conductscience.org/library/papers/4119511PubMed
164,113,225HL-A antigens and multiple sclerosis.Lancet1972https://conductscience.org/library/papers/4113225PubMed
174,129,810Multiple sclerosis: a two-phase disease?Acta Neurol Scand1973https://conductscience.org/library/papers/4129810PubMed
181,097,604Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.J Neurol Neurosurg Psychiatry1975https://conductscience.org/library/papers/1097604PubMed
194,632,435Long-term treatment of multiple sclerosis with azathioprine.J Neurol Neurosurg Psychiatry1973https://conductscience.org/library/papers/4632435PubMed
2048,077Letter: Linoleic acid as an immunosuppressive agent.Lancet1975https://conductscience.org/library/papers/48077PubMed
21938,265Antibodies to vaccinia and measles viruses in multiple sclerosis patients.Arch Neurol1976https://conductscience.org/library/papers/938265PubMed
221,237,376Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.Clin Exp Immunol1975https://conductscience.org/library/papers/1237376PubMed
231,180,478Multiple sclerosis: immunologic aspects.Ann Clin Lab Sci1975https://conductscience.org/library/papers/1180478PubMed
241,169,710Proceedings: Transfer factor treatment in multiple sclerosis.Neurology1975https://conductscience.org/library/papers/1169710PubMed
255,411,678Studies on the natural history of multiple sclerosis. V. Long-term survival in young men.Arch Neurol1970https://conductscience.org/library/papers/5411678PubMed

See all 21 references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
39,651,635Azathioprine for people with multiple sclerosis.Cochrane Database Syst Rev2024https://conductscience.org/library/papers/39651635PubMed
18,175,075Azathioprine. Safety profile in multiple sclerosis patients.Neurol Sci2007https://conductscience.org/library/papers/18175075PubMed
17,943,809Azathioprine for multiple sclerosis.Cochrane Database Syst Rev2007https://conductscience.org/library/papers/17943809PubMed
8,326,334A double blind study on azathioprine efficacy in multiple sclerosis: final report.J Neurol1993https://conductscience.org/library/papers/8326334PubMed
6,196,462Immunological treatment of multiple sclerosis.J Neurol1983https://conductscience.org/library/papers/6196462PubMed
6,164,763Short-term intensive cyclophosphamide treatment in multiple sclerosis. A retrospective controlled study.J Neurol1981https://conductscience.org/library/papers/6164763PubMed
6,157,007Azathioprine in multiple sclerosis--a 3 year controlled study of its effectiveness.J Neurol1980https://conductscience.org/library/papers/6157007PubMed
3,403,219Effectiveness of azathioprine treatment in multiple sclerosis.Ital J Neurol Sci1988https://conductscience.org/library/papers/3403219PubMed
3,281,916Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results.Ital J Neurol Sci1988https://conductscience.org/library/papers/3281916PubMed
2,982,564Multiple sclerosis. Current concepts in management.Drugs1985https://conductscience.org/library/papers/2982564PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/458481

GET https://conductscience.org/api/papers/v1/458481/references?page=2

API referenceFor AI assistants